CIK 0001902794
MGOL MGO Global Inc.
Insider trading from SEC Form 4. Last filing Jan 8, 2025.
MGO Global Inc. (MGOL) has 2 SEC Form 4 filings on file from 2 insiders, the latest filed on Jan 8, 2025. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Signals
Open-market buys and sells at MGO Global Inc., scored.
Transactions
Every row filed, 2 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 7, 2025 | Julian Groves CHIEF OPERATING OFFICER | AGrant or award Common Stock | +15,000 | $0.00 | $0 | 168,664 | Jan 8, 2025 |
| Jan 7, 2025 | Virginia Hilfiger CHIEF BRAND OFFICER | AGrant or award Common Stock | +15,000 | $0.00 | $0 | 472,177 | Jan 8, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Julian GrovesCHIEF OPERATING OFFICER
- Virginia HilfigerCHIEF BRAND OFFICER
Questions about MGOL
Answered from the filings on this page, as of the latest one.
Are insiders buying MGOL?
No. In the last 90 days no insider at MGO Global Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade MGOL on the open market?
No open-market trade has been scored at MGO Global Inc.. The latest Form 4 on file was filed on Jan 8, 2025 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at MGO Global Inc.?
2 people have filed a Form 4 at MGO Global Inc., among them Julian Groves (CHIEF OPERATING OFFICER), Virginia Hilfiger (CHIEF BRAND OFFICER). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.